These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28440401)

  • 1. Relationship between T-cell receptor beta chain sequences and human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.
    Wu Z; Zhang H; Jin M; Liang H; Huang Y; Yang R; Gui G; Wang H; Gong S; Wang J; Fan J
    Mol Med Rep; 2017 Jun; 15(6):3898-3904. PubMed ID: 28440401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [T cell receptor β-chain CDR3 spectratyping and cytomegalovirus activation in allogeneic hematopoietic stem cell transplant recipients].
    Wu Z; Jing M; Liang H; Yang R; Huang Y; Chen X; Hu J; Fan J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(5):515-521. PubMed ID: 28087912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients.
    Tormo N; Solano C; Benet I; Clari MA; Nieto J; de la Cámara R; López J; López-Aldeguer N; Hernández-Boluda JC; Remigia MJ; Garcia-Noblejas A; Gimeno C; Navarro D
    Bone Marrow Transplant; 2010 Mar; 45(3):543-9. PubMed ID: 19617905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution of cytomegalovirus-specific T-cell response in allogeneic hematopoietic stem cell recipients: the contribution of six frequently recognized, virus-encoded ORFs.
    Nemeckova S; Krystofova J; Babiarova K; Hainz P; Musil J; Sroller V; Maly M; Stastna-Markova M
    Transpl Infect Dis; 2016 Jun; 18(3):381-9. PubMed ID: 27061389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation].
    Fu YW; Wu DP; Sun AN; Feng YF; Chang WR; Zhu ZL; Zhu P
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):312-7. PubMed ID: 17877159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpesvirus infections in hematopoietic stem cell transplant recipients seropositive for human cytomegalovirus before transplantation.
    Fan J; Jing M; Yang M; Xu L; Liang H; Huang Y; Yang R; Gui G; Wang H; Gong S; Wang J; Zhang X; Zhao H; Gao H; Dong H; Ma W; Hu J
    Int J Infect Dis; 2016 May; 46():89-93. PubMed ID: 27057748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation.
    Link CS; Eugster A; Heidenreich F; Rücker-Braun E; Schmiedgen M; Oelschlägel U; Kühn D; Dietz S; Fuchs Y; Dahl A; Domingues AM; Klesse C; Schmitz M; Ehninger G; Bornhäuser M; Schetelig J; Bonifacio E
    Clin Exp Immunol; 2016 Jun; 184(3):389-402. PubMed ID: 26800118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the cytomegalovirus pp65 antigenemia assay for preemptive therapy in allogeneic hematopoietic stem cell transplantation: a real-world review.
    Tan BH; Chlebicka NL; Low JG; Chong TY; Chan KP; Goh YT
    Transpl Infect Dis; 2008 Oct; 10(5):325-32. PubMed ID: 18627578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ELISPOT assay of interferon-γ secretion for evaluating human cytomegalovirus reactivation risk in allo-HSCT recipients.
    Liang H; Xia J; Zhang R; Yang B; Wu J; Gui G; Huang Y; Chen X; Yang R; Wang H; Gong S; Fan J
    J Med Virol; 2021 Nov; 93(11):6301-6308. PubMed ID: 34076905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring human cytomegalovirus infection in pediatric hematopoietic stem cell transplant recipients: using an affordable in-house qPCR assay for management of HCMV infection under limited resources.
    Khansarinejad B; Soleimanjahi H; Mirab Samiee S; Hamidieh AA; Paryan M; Sanahmadi Y; Karami M; Mondanizadeh M
    Transpl Int; 2015 May; 28(5):594-603. PubMed ID: 25703481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary exploration of HLA-A 1101-restricted human cytomegalovirus glycoprotein B-specific CD8⁺ T cells in allogeneic stem-cell transplant recipients.
    Liu A; Hu J; Wu W; Huang Y; Liang H; Wang H; Yang R; Fan J
    Virus Res; 2014 Aug; 188():38-44. PubMed ID: 24704672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
    Fleming T; Dunne J; Crowley B
    J Med Virol; 2010 Mar; 82(3):433-40. PubMed ID: 20087937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
    Peggs KS; Mackinnon S
    Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell T-cell receptor-β analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT.
    Nakasone H; Tanaka Y; Yamazaki R; Terasako K; Sato M; Sakamoto K; Yamasaki R; Wada H; Ishihara Y; Kawamura K; Machishima T; Ashizawa M; Kimura SI; Kikuchi M; Tanihara A; Kanda J; Kako S; Nishida J; Kanda Y
    Bone Marrow Transplant; 2014 Jan; 49(1):87-94. PubMed ID: 23933763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells.
    Peggs K; Verfuerth S; Pizzey A; Ainsworth J; Moss P; Mackinnon S
    Blood; 2002 Jan; 99(1):213-23. PubMed ID: 11756174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell vaccination in an allogeneic stem cell recipient receiving a transplant from a human cytomegalovirus (HCMV)-seronegative donor: induction of a HCMV-specific T(helper) cell response.
    Feuchtinger T; Opherk K; Bicanic O; Schumm M; Grigoleit GU; Hamprecht K; Jahn G; Handgretinger R; Lang P
    Cytotherapy; 2010 Nov; 12(7):945-50. PubMed ID: 20230226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
    Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays.
    Liu A; Ma Y; Wu W; Chen X; Huang Y; Hu J; Liang H; Wang H; Yang R; Fan J
    J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunosuppressive effect of human cytomegalovirus infection in recipients of allogeneic hematopoietic stem cell transplantation.
    Giebel S; Maccario R; Lilleri D; Zecca M; Avanzini MA; Marconi M; Di Cesare Merlone A; Campanini G; Montagna D; Travaglino P; Gentile R; Telli S; Pagliara D; Holowiecki J; Locatelli F
    Bone Marrow Transplant; 2005 Sep; 36(6):503-9. PubMed ID: 16007103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection in lung transplantation as detected with recombinant and naturally occurring proteins.
    van Zanten J; Harmsen MC; van der Giessen M; van der Bij W; Prop J; de Leij L; The TH
    Clin Diagn Lab Immunol; 1995 Mar; 2(2):214-8. PubMed ID: 7535179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.